Table 2.
Prevalence of NOD2 3020insC mutation in breast cancer patients, according to age at onset
| Age groups | Prevalence of NOD2 3020insC |
|---|---|
| <41 | 0% (0/10) |
| 41-50 | 9.7% (3/31) |
| 51-60 | 17% (8/46)* |
| 61-70 | 7.3% (4/55) |
| >70 | 4.9% (2/41) |
| total | 9.1% (17/185) |
* - statistically significant difference as compared to population controls (7.7% (75/974); OR = 2.5, p < 0.05)